204 related articles for article (PubMed ID: 26193918)
1. Lacrimal Gland Volume Changes in Unilateral Primary Acquired Nasolacrimal Obstruction.
Yazici A; Bulbul E; Yazici H; Sari E; Tiskaoglu N; Yanik B; Ermis S
Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4425-9. PubMed ID: 26193918
[TBL] [Abstract][Full Text] [Related]
2. Lacrimal gland activity in lacrimal drainage obstruction: exploring the potential cross-talk between the tear secretion and outflow.
Singh S; Srivastav S; Bothra N; Paulsen F; Ali MJ
Br J Ophthalmol; 2024 Mar; 108(4):621-624. PubMed ID: 37142331
[TBL] [Abstract][Full Text] [Related]
3. Prospective controlled study of vapor pressure tear osmolality and tear meniscus height in nasolacrimal duct obstruction.
Stahl U; Francis IC; Stapleton F
Am J Ophthalmol; 2006 Jun; 141(6):1051-6. PubMed ID: 16765672
[TBL] [Abstract][Full Text] [Related]
4. Reduced tear break-up time in the fellow eye of patients with unilateral primary acquired nasolacrimal duct obstruction.
Tıskaoğlu NS; Yazıcı A
Int Ophthalmol; 2023 Mar; 43(3):965-971. PubMed ID: 36053478
[TBL] [Abstract][Full Text] [Related]
5. Tear instability in the fellow eye of unilateral nasolacrimal obstruction and resolution with dacryocystorhinostomy.
Tıskaoğlu NS; Yazıcı A
Orbit; 2023 Aug; 42(4):404-410. PubMed ID: 36069079
[TBL] [Abstract][Full Text] [Related]
6. Videoreflective dacryomeniscometry in normal adults and in patients with functional or primary acquired nasolacrimal duct obstruction.
Francis IC; Chan DG; Papalkar D; Papas EB; Stapleton F
Am J Ophthalmol; 2005 Mar; 139(3):493-7. PubMed ID: 15767059
[TBL] [Abstract][Full Text] [Related]
7. Changes in the meibomian glands in postmenopausal women with primary acquired nasolacrimal duct obstruction: a prospective study.
Jin H; Zhang H
BMC Ophthalmol; 2023 Feb; 23(1):48. PubMed ID: 36726065
[TBL] [Abstract][Full Text] [Related]
8. Lacrimal Fossa Bony Changes in Chronic Primary Acquired Nasolacrimal Duct Obstruction and Acute Dacryocystitis.
Ali MJ; Mishra DK; Bothra N
Curr Eye Res; 2021 Aug; 46(8):1132-1136. PubMed ID: 33583297
[TBL] [Abstract][Full Text] [Related]
9. Morphometric Evaluation of Bony Nasolacrimal Canal in a Caucasian Population with Primary Acquired Nasolacrimal Duct Obstruction: A Multidetector Computed Tomography Study.
Bulbul E; Yazici A; Yanik B; Yazici H; Demirpolat G
Korean J Radiol; 2016; 17(2):271-6. PubMed ID: 26957913
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of primary acquired nasolacrimal duct obstruction.
Kashkouli MB; Sadeghipour A; Kaghazkanani R; Bayat A; Pakdel F; Aghai GH
Orbit; 2010 Feb; 29(1):11-5. PubMed ID: 20302403
[TBL] [Abstract][Full Text] [Related]
11. Meibomian Gland Dysfunction in Primary Acquired Nasolacrimal Duct Obstruction.
Yoon S; Lee H; Baek S
J Craniofac Surg; 2023 Jun; 34(4):e395-e398. PubMed ID: 37157128
[TBL] [Abstract][Full Text] [Related]
12. Conjunctival cytologic features in patients with unilateral primary acquired nasolacrimal duct obstruction.
Yuksel N; Mutlu M; Kilicarslan A; Akcay E
Int Ophthalmol; 2018 Feb; 38(1):323-326. PubMed ID: 28224303
[TBL] [Abstract][Full Text] [Related]
13. Alteration of Tear Cytokine Expressions in Primary Acquired Nasolacrimal Duct Obstruction - Potential Insights into the Etiopathogenesis.
Ali MJ; Patnaik S; Kelkar N; Ali MH; Kaur I
Curr Eye Res; 2020 Apr; 45(4):435-439. PubMed ID: 31490706
[No Abstract] [Full Text] [Related]
14. Dry eye and decreased tear film stability in primary acquired nasolacrimal duct obstruction patients.
Yu X; Wang K; Hu Y; Meng Z; Li J; Liu Y; Xiao L; Chen M; Li S; Shen Y; Chen R; Liang X
Int Ophthalmol; 2024 Jun; 44(1):277. PubMed ID: 38916702
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of both lacrimal glands in unilateral primary acquired nasolacrimal duct obstruction, based on three-dimensional fast spin echo-Cube-Flex.
Zhao Y; Tian M; Luo B; Liang W; Wu H; Wang Q; Zhang J
Eur J Radiol; 2022 Nov; 156():110517. PubMed ID: 36108476
[TBL] [Abstract][Full Text] [Related]
16. Tear meniscus measurement in nasolacrimal duct obstruction patients with Fourier-domain optical coherence tomography: novel three-point capture method.
Park DI; Lew H; Lee SY
Acta Ophthalmol; 2012 Dec; 90(8):783-7. PubMed ID: 21726426
[TBL] [Abstract][Full Text] [Related]
17. Electrolytes and electrophoretic studies of tear proteins in tears of patients with nasolacrimal duct obstruction.
Lew H; Yun YS; Lee SY
Ophthalmologica; 2005; 219(3):142-6. PubMed ID: 15947499
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic analysis of 166 patients with primary acquired nasolacrimal duct obstruction.
Lee-Wing MW; Ashenhurst ME
Ophthalmology; 2001 Nov; 108(11):2038-40. PubMed ID: 11713075
[TBL] [Abstract][Full Text] [Related]
19. Topical glaucoma therapy as a risk factor for nasolacrimal duct obstruction.
Seider N; Miller B; Beiran I
Am J Ophthalmol; 2008 Jan; 145(1):120-123. PubMed ID: 17915187
[TBL] [Abstract][Full Text] [Related]
20. The Micro-Reflux Test: a new test to evaluate nasolacrimal duct obstruction.
Camara JG; Santiago MD; Rodriguez RE; Medalle RA; Young DA; Atebara NH
Ophthalmology; 1999 Dec; 106(12):2319-21. PubMed ID: 10599664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
